CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
-26.27%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$2.23B
AUM Growth
-$1.32B
(-37%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
55.24%
Holding
55
New
2
Increased
1
Reduced
7
Closed
8
Top Buys
| 1 |
TSVT
2seventy bio
TSVT
|
+$10.5M |
| 2 |
Twist Bioscience
TWST
|
+$10.4M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$8.43M |
Top Sells
| 1 |
Codexis
CDXS
|
+$83.1M |
| 2 |
Exact Sciences
EXAS
|
+$49.6M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$43M |
| 4 |
Allogene Therapeutics
ALLO
|
+$39.5M |
| 5 |
Alector
ALEC
|
+$34.1M |
Sector Composition
| 1 | Healthcare | 95.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
908 Devices
MASS
$217M
| – | – |
-406,502
| Closed | -$10.5M |
|
52
Sana Biotechnology
SANA
$831M
| – | – |
-60,000
| Closed | -$929K |
|
53
Stoke Therapeutics
STOK
$1.28B
| – | – |
-120,000
| Closed | -$2.88M |
|
|
ME
54
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| – | – |
-92,073
| Closed | -$12.3M |
|
|
CELL
55
DELISTED
PhenomeX Inc. Common Stock
CELL
| – | – |
-200,000
| Closed | -$3.64M |
|